Company / AR per Share
Cytokinetics AR per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$147.91
FY2025
5-year range
$0.00 / $147.91
FY2021-FY2025
Trend
+90187.7%
vs FY2024
Sector context
#2 of 113
Health Care
What the data says
AR per Share changed +90188% YoY in FY2025, a notable deviation from the 8-year average annual change of +11618%.
Based on SEC 10-K filings.
147.91 in FY2025 with a 5-year CAGR of +373.4%. Ranks 2nd among 113 companies in Health Care.
Improved from $0.01 to $147.91 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +373.4%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 113This company $147.91 Sector average $28.83
▼
+413.0% above sector average
Key checks
Key Insights
- Cytokinetics's ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 90187.7% year-over-year.
- Ranks #2 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $147.91 | +90187.7% |
| FY2024 | $0.16 | +1110.9% |
| FY2023 | $0.01 | +680.4% |
| FY2022 | $0.00 | -99.7% |
| FY2021 | $0.61 | +881.8% |
| FY2020 | $0.06 | -28.7% |
| FY2019 | $0.09 | +114.0% |
| FY2018 | $0.04 | +97.9% |
| FY2017 | $0.02 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026